New Screening Methods in Melanoma

被引：0

作者：

Czerw, Aleksandra ^{[1
,2
]}

Deptala, Andrzej ^{[3
]}

Partyka, Olga ^{[1
,2
]}

Pajewska, Monika ^{[1
,2
]}

Badowska-Kozakiewicz, Anna ^{[3
]}

Budzik, Michal ^{[3
]}

Sygit, Katarzyna ^{[4
]}

Kopczynski, Zygmunt ^{[4
]}

Czarnywojtek, Piotr ^{[5
]}

Cipora, Elzbieta ^{[6
]}

Konieczny, Magdalena ^{[6
]}

Banas, Tomasz ^{[7
]}

Grochans, Elzbieta ^{[8
]}

Grochans, Szymon ^{[9
]}

Cybulska, Anna Maria ^{[8
]}

Schneider-Matyka, Daria ^{[8
]}

Bandurska, Ewa ^{[10
]}

Ciecko, Weronika ^{[10
]}

Drobnik, Jaroslaw ^{[11
]}

Pobrotyn, Piotr ^{[12
]}

Grata-Borkowska, Urszula ^{[11
]}

Furtak-Pobrotyn, Joanna ^{[13
]}

Sierocka, Aleksandra ^{[14
]}

Marczak, Michal ^{[15
]}

Kozlowski, Remigiusz ^{[14
]}

机构：

[1] Med Univ Warsaw, Dept Hlth Econ & Med Law, PL-01445 Warsaw, Poland

[2] Natl Inst Publ Hlth NIH, Natl Res Inst, Dept Econ & Syst Anal, PL-00791 Warsaw, Poland

[3] Med Univ Warsaw, Dept Oncol Propaedeut, PL-01445 Warsaw, Poland

[4] Calis Univ, Fac Med & Hlth Sci, PL-62800 Kalisz, Poland

[5] Calis Univ, Polytech Fac, PL-62800 Kalisz, Poland

[6] Jan Grodek State Univ Sanok, Med Inst, PL-38500 Sanok, Poland

[7] Mar Sklodowska Curie Natl Res Inst Oncol, Dept Radiotherapy, PL-44102 Krakow, Poland

[8] Pomeranian Med Univ, Fac Hlth Sci, Dept Nursing, PL-71210 Szczecin, Poland

[9] Pomeranian Med Univ, Dept Pediat & Oncol Surg Urol & Hand Surg, Dept Pediat & Oncol Surg Urol & Hand Surg, Szczecin, Poland

[10] Med Univ Gdansk, Ctr Competence Dev Integrated Care & eHlth, PL-80204 Gdansk, Poland

[11] Wroclaw Med Univ, Fac Med, Dept Family Med, PL-51141 Wroclaw, Poland

[12] Pulsantis Specialist & Rehabil Clin Ltd, PL-53238 Wroclaw, Poland

[13] Citodent Dent Ctr Furtak Pobrotyn & Co Ltd Partner, PL-05220 Olawa, Poland

[14] Med Univ Lodz, Dept Management & Logist Healthcare, PL-90131 Lodz, Poland

[15] Merito Univ Poznan, Dept Innovat, PL-61895 Poznan, Poland

来源：

CANCERS | 2024年 / 16卷 / 24期

关键词：

melanoma; MM; screening; clinical trials; RISK;

D O I：

10.3390/cancers16244186

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: The World Health Organisation reports that melanoma had an incidence of 331,722 cases worldwide in 2022, ranking it 17th on the list of the most prevalent malignancies. This disease is a threat to public health as years of potential life lost from melanoma deaths constitute an economic and social burden; it is, however, curable if detected early. This study aims to show current trends in clinical trials for melanoma screening. Materials and Methods: The analysis was conducted using data from clinicaltrials.gov. The analysis considered both interventional and observational studies on melanoma screening. Only the studies with complete and active statutes by 4 September 2024 were included in the analysis. Results: Out of 25 studies registered in clinical trial databases regarding melanoma screening, 20% research advanced imagining techniques employing innovative machine learning algorithms, while 16% explore behavioural interventions. Conclusions: Intensification of behavioural interventions and health promotion activities is recommended.

引用

页数：10

共 50 条

[31] A comparative study of fragment screening methods on the p38α kinase: new methods, new insights
Scott J. Pollack
Kim S. Beyer
Christopher Lock
Ilka Müller
David Sheppard
Mike Lipkin
David Hardick
Peter Blurton
Philip M. Leonard
Paul A. Hubbard
Daniel Todd
Christine M. Richardson
Thomas Ahrens
Manuel Baader
Doris O. Hafenbradl
Kate Hilyard
Roland W. Bürli
Journal of Computer-Aided Molecular Design, 2011, 25 : 677 - 687
[32] Biopsy methods for melanoma: Evidence review and recommendations from new Australian melanoma clinical practice guidelines
Kelly, J.
de Menezes, S.
Scolyer, R.
Beer, T.
Fishburn, P.
Soyer, H. P.
Ng, J.
Damian, D.
Thompson, J.
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 : 29 - 29
[33] Screening of metabolic modulators identifies new strategies to target metabolic reprogramming in melanoma
Cecilie Abildgaard
Salvatore Rizza
Helle Christiansen
Steffen Schmidt
Christina Dahl
Ahmad Abdul-Al
Annette Christensen
Giuseppe Filomeni
Per Guldberg
Scientific Reports, 11
[34] Screening of metabolic modulators identifies new strategies to target metabolic reprogramming in melanoma
Abildgaard, Cecilie
Rizza, Salvatore
Christiansen, Helle
Schmidt, Steffen
Dahl, Christina
Abdul-Al, Ahmad
Christensen, Annette
Filomeni, Giuseppe
Guldberg, Per
SCIENTIFIC REPORTS, 2021, 11 (01)
[35] SCREENING FOR MELANOMA RISK IS MISGUIDED
KEELEY, D
BRITISH MEDICAL JOURNAL, 1995, 310 (6984): : 916 - 916
[36] Uveal Melanoma: Screening Is Useless
Gombos, Dan S.
OPHTHALMOLOGICA, 2014, 232 : 23 - 24
[37] Hyperspectral Imaging for Melanoma Screening
Martin, Justin
Krueger, James
Gareau, Daniel
PHOTONIC THERAPEUTICS AND DIAGNOSTICS X, 2014, 8926
[38] Melanoma Screening-Reply
Swerlick, Robert A.
JAMA DERMATOLOGY, 2022, 158 (11) : 1332 - 1333
[39] Melanoma Screening with Cellular Phones
Massone, Cesare
Hofmann-Wellenhof, Rainer
Ahlgrimm-Siess, Verena
Gabler, Gerald
Ebner, Christoph
Soyer, H. Peter
PLOS ONE, 2007, 2 (05):
[40] Melanoma Screening COMMENT & RESPONSE
Elwood, Mark
Aitken, Joanne
Soyer, Peter
JAMA DERMATOLOGY, 2022, 158 (11) : 1332 - 1333

← 1 2 3 4 5 →